Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

Pfizer Inc. agreed Friday to settle a lawsuit over the diabetes drug Rezulin after a jury earlier in the day awarded $43 million to a Texas woman who said it destroyed her liver.

Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or ... :198-206. doi: 10.1046/j.1365-2516.2001.00484.x.

Pfizer, according to the documents, ... That study initially seems to have yielded negative results—but when it was published in 2001 in the journal Headache, ...

Pfizer is facing a penicillin shortage that may stretch into 2024 The shortage comes as there has been a steady increase in rates of ... Syphilis rates were at a historic low from 2000 to 2001, ...

Pfizer Inc. will scrutinize hundreds of drug and biotechnology companies this year in a hunt for the next $1 billion medicine, company officials said. Pfizer, the world's largest drug maker, has ...

Pfizer is buying Seattle-area biotech giant Seagen in a massive $43 billion deal announced Monday. ... It went public in 2001, pricing its IPO at $7 per share.

Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The deal will close on Thursday. Seagen is the largest biotech ...

Pfizer is spending about $43 billion to acquire Seagen, the Bothell-based biotech giant formerly known as Seattle Genetics. ... which was founded in 1997 and went public in 2001.

Pfizer’s (NYSE:PFE) Vyndamax, priced at $20.6K for a 28-day supply, ... for its gene editing therapy NTLA-2001, and Ionis ...

NEW YORK, NY, USA I June 26, 2025 I Pfizer Inc. (NYSE: PFE)today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating ...

Syphilis rates were at a historic low from 2000 to 2001, but have increased every year since, with an increase of 28.6% from 2020 to 2021, which was likely exacerbated by an interruption in ...